Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2011 2
2012 1
2019 4
2020 2
2021 6
2022 4
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

17 results

Results by year

Filters applied: . Clear all
Page 1
Cardiovascular Safety of Degarelix Versus Leuprolide in Patients With Prostate Cancer: The Primary Results of the PRONOUNCE Randomized Trial.
Lopes RD, Higano CS, Slovin SF, Nelson AJ, Bigelow R, Sørensen PS, Melloni C, Goodman SG, Evans CP, Nilsson J, Bhatt DL, Clarke NW, Olesen TK, Doyle-Olsen BT, Kristensen H, Arney L, Roe MT, Alexander JH; PRONOUNCE Study Investigators. Lopes RD, et al. Circulation. 2021 Oct 19;144(16):1295-1307. doi: 10.1161/CIRCULATIONAHA.121.056810. Epub 2021 Aug 30. Circulation. 2021. PMID: 34459214 Free PMC article. Clinical Trial.
Proton therapy for head and neck squamous cell carcinomas: A review of the physical and clinical challenges.
Beddok A, Vela A, Calugaru V, Tessonnier T, Kubes J, Dutheil P, Gerard A, Vidal M, Goudjil F, Florescu C, Kammerer E, Benezery K, Herault J, Poortmans P, Bourhis J, Thariat J; GORTEC, the 3 French proton centers. Beddok A, et al. Among authors: kubes j. Radiother Oncol. 2020 Jun;147:30-39. doi: 10.1016/j.radonc.2020.03.006. Epub 2020 Mar 27. Radiother Oncol. 2020. PMID: 32224315 Review.
Current practice in proton therapy delivery in adult cancer patients across Europe.
Tambas M, van der Laan HP, Steenbakkers RJHM, Doyen J, Timmermann B, Orlandi E, Hoyer M, Haustermans K, Georg P, Burnet NG, Gregoire V, Calugaru V, Troost EGC, Hoebers F, Calvo FA, Widder J, Eberle F, van Vulpen M, Maingon P, Skóra T, Weber DC, Bergfeldt K, Kubes J, Langendijk JA. Tambas M, et al. Among authors: kubes j. Radiother Oncol. 2022 Feb;167:7-13. doi: 10.1016/j.radonc.2021.12.004. Epub 2021 Dec 11. Radiother Oncol. 2022. PMID: 34902370 Free article.
Proton Therapy in Supradiaphragmatic Lymphoma: Predicting Treatment-Related Mortality to Help Optimize Patient Selection.
Ntentas G, Dedeckova K, Andrlik M, Aznar MC, Shakir R, Ramroth J, Begum R, Kubeš J, Darby SC, Mikhaeel NG, Cutter DJ. Ntentas G, et al. Among authors: kubes j. Int J Radiat Oncol Biol Phys. 2022 Mar 15;112(4):913-925. doi: 10.1016/j.ijrobp.2021.10.151. Epub 2021 Nov 9. Int J Radiat Oncol Biol Phys. 2022. PMID: 34762970 Free PMC article.
Pencil-beam scanning proton therapy for the treatment of glomus jugulare tumours.
Kubeš J, Vondráček V, Andrlik M, Navrátil M, Sláviková S, Klika D, Haas A, Dědečková K, Kopečková K, Ondrová B, Rotnáglová E, Vinakurau Š, Grebenyuk A, Rosina J. Kubeš J, et al. J Med Radiat Sci. 2022 Dec;69(4):456-462. doi: 10.1002/jmrs.612. Epub 2022 Aug 16. J Med Radiat Sci. 2022. PMID: 35973945 Free PMC article.
Ultrahypofractionated Proton Radiation Therapy in the Treatment of Low and Intermediate-Risk Prostate Cancer-5-Year Outcomes.
Kubeš J, Haas A, Vondráček V, Andrlík M, Navrátil M, Sláviková S, Vítek P, Dědečková K, Prausová J, Ondrová B, Vinakurau Š, Grebenyuk A, Doležal T, Velacková B, Rosina J. Kubeš J, et al. Int J Radiat Oncol Biol Phys. 2021 Jul 15;110(4):1090-1097. doi: 10.1016/j.ijrobp.2021.02.014. Epub 2021 Feb 12. Int J Radiat Oncol Biol Phys. 2021. PMID: 33587990
5-Years Analysis of Effectivity and Toxicity of Ultra-Hypofractionated Proton Radiotherapy in the Treatment of Low- and Intermediate-Risk Prostate Cancer-A Retrospective Analysis.
Kubeš J, Sláviková S, Vítek P, Haas A, Ondrová B, Dedečková K, Andrlík M, Domanský M, Jiránková K, Schlencová V, Harazimová A, Turková B, Doležal T, Al-Hamami SFA, Vondráček V. Kubeš J, et al. Cancers (Basel). 2023 Sep 15;15(18):4571. doi: 10.3390/cancers15184571. Cancers (Basel). 2023. PMID: 37760540 Free PMC article.
17 results